Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 vaccines in Hong Kong
In conclusion, our data showed that vaccination with BNT162b2 induces stronger humoral responses than CoronaVac. However, CoronaVac induces higher CD4+ and CD8+ T-cell responses to the structural protein than BNT162b2.